Managing Nausea with Carbidopa Levodopa Infusion

First-Line Treatments

Dopamine receptor antagonists such as metoclopramide, prochlorperazine, or haloperidol should be used as first-line treatment for nausea associated with carbidopa levodopa infusion, as recommended by the National Comprehensive Cancer Network 1, 2
The American College of Physicians and other guideline societies support the use of dopamine receptor antagonists, including metoclopramide (20-30 mg) and prochlorperazine (10-20 mg), for the management of nausea associated with carbidopa levodopa infusion 2, 3

For persistent nausea, switching to scheduled administration of antiemetics rather than as-needed dosing, and administering them around the clock for 1 week, is recommended by the National Comprehensive Cancer Network 2, 4
Adding medications with different mechanisms of action, such as 5-HT3 receptor antagonists (e.g., ondansetron, granisetron) and corticosteroids (e.g., dexamethasone, methylprednisolone), may be beneficial for patients with persistent nausea, as suggested by the National Comprehensive Cancer Network 2, 4, 5

Ruling out other causes of nausea, such as constipation, CNS pathology, electrolyte disturbances, gastroesophageal reflux, and medication interactions, is crucial in the management of nausea associated with carbidopa levodopa infusion, as recommended by the National Comprehensive Cancer Network 1, 2, 5
Prophylactic antiemetic treatment is highly recommended for patients with a prior history of levodopa-induced nausea, and should be started before initiating carbidopa levodopa therapy, according to the National Comprehensive Cancer Network 2, 3, 5

Ensuring adequate hydration is essential in the management of nausea associated with carbidopa levodopa infusion, as dehydration can worsen both nausea and other Parkinson's symptoms, as noted by the National Comprehensive Cancer Network 1